Annual Retained Earnings
-$112.09 M
-$29.07 M-35.01%
31 December 2023
Summary:
Enlivex Therapeutics annual retained earnings is currently -$112.09 million, with the most recent change of -$29.07 million (-35.01%) on 31 December 2023. During the last 3 years, it has fallen by -$74.60 million (-198.94%). ENLV annual retained earnings is now -48848.91% below its all-time high of -$229.00 thousand, reached on 31 December 2012.ENLV Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$119.33 M
-$3.10 M-2.66%
30 June 2024
Summary:
Enlivex Therapeutics quarterly retained earnings is currently -$119.33 million, with the most recent change of -$3.10 million (-2.66%) on 30 June 2024. Over the past year, it has dropped by -$16.33 million (-15.86%). ENLV quarterly retained earnings is now -8423.50% below its all-time high of -$1.40 million, reached on 31 December 2013.ENLV Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENLV Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.0% | -15.9% |
| 3 y3 years | -198.9% | -152.7% |
| 5 y5 years | -588.1% | -423.2% |
ENLV Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -198.9% | at low | -152.7% | at low |
| 5 y | 5 years | -588.1% | at low | -423.2% | at low |
| alltime | all time | <-9999.0% | at low | -8423.5% | at low |
Enlivex Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -$119.33 M(+2.7%) |
| Mar 2024 | - | -$116.23 M(+3.7%) |
| Dec 2023 | -$112.09 M(+35.0%) | -$112.09 M(+8.8%) |
| Sept 2023 | - | -$103.00 M(+6.1%) |
| June 2023 | - | -$97.03 M(+7.5%) |
| Mar 2023 | - | -$90.24 M(+8.7%) |
| Dec 2022 | -$83.03 M(+59.8%) | -$83.03 M(+9.5%) |
| Sept 2022 | - | -$75.84 M(+8.2%) |
| June 2022 | - | -$70.10 M(+16.5%) |
| Mar 2022 | - | -$60.19 M(+15.8%) |
| Dec 2021 | -$51.97 M(+38.6%) | -$51.97 M(+10.0%) |
| Sept 2021 | - | -$47.23 M(+7.8%) |
| June 2021 | - | -$43.80 M(+7.6%) |
| Mar 2021 | - | -$40.70 M(+8.5%) |
| Dec 2020 | -$37.50 M(+46.1%) | -$37.50 M(+18.5%) |
| Sept 2020 | - | -$31.63 M(+7.2%) |
| June 2020 | - | -$29.51 M(+11.5%) |
| Mar 2020 | - | -$26.47 M(+3.1%) |
| Dec 2019 | -$25.67 M | -$25.67 M(+12.6%) |
| Sept 2019 | - | -$22.81 M(+11.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | -$20.41 M(+7.7%) |
| Mar 2019 | - | -$18.95 M(+16.4%) |
| Dec 2018 | -$16.29 M(-64.4%) | -$16.29 M(-65.7%) |
| June 2018 | - | -$47.45 M(+3.7%) |
| Dec 2017 | -$45.75 M(+14.9%) | -$45.75 M(+1.3%) |
| Sept 2017 | - | -$45.19 M(+2.4%) |
| June 2017 | - | -$44.11 M(+3.8%) |
| Mar 2017 | - | -$42.48 M(+6.7%) |
| Dec 2016 | -$39.81 M(+67.4%) | -$39.81 M(+8.4%) |
| Sept 2016 | - | -$36.74 M(+14.6%) |
| June 2016 | - | -$32.07 M(+13.0%) |
| Mar 2016 | - | -$28.38 M(+19.3%) |
| Dec 2015 | -$23.79 M(+182.4%) | -$23.79 M(+25.5%) |
| Sept 2015 | - | -$18.96 M(+23.0%) |
| June 2015 | - | -$15.41 M(+31.4%) |
| Mar 2015 | - | -$11.72 M(+39.2%) |
| Dec 2014 | -$8.42 M(+501.6%) | -$8.42 M(+59.8%) |
| Sept 2014 | - | -$5.27 M(+66.9%) |
| June 2014 | - | -$3.16 M(+125.6%) |
| Dec 2013 | -$1.40 M(+511.4%) | -$1.40 M |
| Dec 2012 | -$229.00 K | - |
FAQ
- What is Enlivex Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual retained earnings year-on-year change?
- What is Enlivex Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly retained earnings year-on-year change?
What is Enlivex Therapeutics annual retained earnings?
The current annual retained earnings of ENLV is -$112.09 M
What is the all time high annual retained earnings for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual retained earnings is -$229.00 K
What is Enlivex Therapeutics annual retained earnings year-on-year change?
Over the past year, ENLV annual retained earnings has changed by -$29.07 M (-35.01%)
What is Enlivex Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ENLV is -$119.33 M
What is the all time high quarterly retained earnings for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly retained earnings is -$1.40 M
What is Enlivex Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ENLV quarterly retained earnings has changed by -$16.33 M (-15.86%)